Penumbra, Inc. PEN is likely to grow in the coming quarters, backed by the strength exhibited in the Thrombectomy business. The company’s robust portfolio expansion looks promising. However, the impact...
Bruker Corporation BRKR recently announced the release of its latest innovative neuroscience research solution, the OptoVolt module, at the Neuroscience 2024 conference. The module uniquely addresses...
Chemed Corporation CHE is expected to grow in the upcoming quarters, backed by the prospects of the VITAS business. Strength within the company’s Roto-rooter brand looks impressive. Meanwhile, Chemed’s...
QIAGEN N.V. QGEN is well-poised to grow in the coming quarter, driven by its strategic alliances with researchers and pharma companies. The company’s expansive next-generation sequencing (NSG) portfolio...
Phibro Animal Health's PAHC diversified product portfolio and wide presence in key growth areas bolster our confidence in the stock. The stock carries a Zacks Rank #2 (Buy).Factors to Drive PAHC's GrowthPhibro’s...
Integra LifeSciences Holdings Corporation IART is well-poised to grow in the coming quarter, driven by healthy sales growth within its Tissue Technologies business despite product recall and manufacturing...
Hyperfine, Inc. HYPR recently announced a publication by investigators at Johns Hopkins Hospital and the University of Texas-Houston on using the Swoop system for patients on extracorporeal membrane oxygenation...